IRF2 regulates cellular survival and Lenvatinib-sensitivity of hepatocellular carcinoma (HCC) through regulating beta-catenin

Guo, YR; Xu, J; Du, Q; Yan, YH; Geller, DA

Geller, DA (corresponding author), Univ Pittsburgh, Dept Surg, Med Ctr, Thomas E Starzl Transplantat Inst, 497 Scaife Hall, Pittsburgh, PA 15260 USA.

TRANSLATIONAL ONCOLOGY, 2021; 14 (6):

Abstract

Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death worldwide. Lenvatinib oral chemotherapy is approved as a first-line ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索